PLSI - Phoenix Life Sciences International Limited

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2/27/2018
2/27/2017
2/28/2016
Total Revenue
-324
-76
-216
-252
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
Selling General and Administrative
3,109
0
4
59
Total Operating Expenses
-
-
-
-
Operating Income or Loss
-
-
-
-
Interest Expense
72
83
137
174
Total Other Income/Expenses Net
-
-
-
-
Income Before Tax
-3,586
-77
-255
-788
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-3,586
-77
-255
-788
Net Income
-3,586
-77
-255
-788
Net Income available to common shareholders
-3,586
-77
-255
-788
Reported EPS
Basic
-
-2.46
-8.63
-28.81
Diluted
-
-2.46
-8.63
-28.81
Weighted average shares outstanding
Basic
-
31
30
27
Diluted
-
31
30
27
EBITDA
-
-
-
-